Sort
30,917 grants matching “tumor microenvironment”
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
$404,975Hayley M. McDaid · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Targeting tumor microenvironment-mediated radiopharmaceutical therapy resistance in prostate cancer
$404,972Evan Robert Abt · University Of California Los Angeles · R21 · FY2025 · CA
Targeting Neoantigens in Glioblastoma
$404,953Gavin Peter Dunn · Washington University · R01 · FY2019 · NS
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$404,924Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2023 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2018 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2017 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2016 · CA
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
$404,888Guangwen Ren · Jackson Laboratory · R37 · FY2025 · CA
Targeting tumor endothelium for cancer surveillance and immunotherapy
$404,888Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2015 · CA
Establishing the Preclinical Model for Metastatic Melanoma
$404,874Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$404,843David D Schlaepfer · University Of California, San Diego · R01 · FY2023 · CA
Reprogramming the Tumor Microenvironment in Ovarian Cancer
$404,843David D Schlaepfer · University Of California, San Diego · R01 · FY2022 · CA
ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY
$404,798Andrew Gunderson · Ohio State University · R01 · FY2024 · CA
Causes and Consequences of Acid pH in Tumors
$404,786University Of Arizona · R01 · FY2004 · CA
Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
$404,719Zachary Conrad Hartman · Duke University · R01 · FY2021 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer
$404,685Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Mechanisms of Tumor Cell Dormancy and Tumor Recurrence
$404,672Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Surgery triggered immune response and liver metastases
$404,645Allan Tsung · University Of Virginia · R01 · FY2025 · CA
Nuclear mechanobiology in confined migration
$404,639Jan Lammerding · Cornell University · R35 · FY2024 · GM
Nuclear mechanobiology in confined migration
$404,639Jan Lammerding · Cornell University · R35 · FY2025 · GM
Translation regulation of the mesenchymal transition by the rRNA and mRNA m6A axis
$404,626Clara Theresa Vincent · New York University School Of Medicine · R01 · FY2024 · CA
Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma
$404,583Yolonda L Colson · Massachusetts General Hospital · R01 · FY2019 · EB
Role of Inflammation in Tax-mediated Tumorigenesis
$404,581Lee Ratner · Ohio State University · P01 · FY2012 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$404,578Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2015 · CA
Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
$404,576Caigang Zhu · University Of Kentucky · R01 · FY2024 · DE